Larry Mattheakis
No más puestos en curso
Perfil
Larry Mattheakis worked as an Assistant Director at Affymax Research Institute from 1992 to 2000.
He then worked as a Senior Scientist at Cytokinetics, Inc. from 2002 to 2007.
From 2007 to 2011, he worked as an Associate Director at Exelixis, Inc. He also served as the Chief Scientific Officer & Executive VP at Annexon, Inc. from 2021 to 2023.
Additionally, he held the position of SVP-Discovery Biology & Translational Research at Protagonist Therapeutics, Inc. Dr. Mattheakis received his undergraduate degree from the University of California and his graduate and doctorate degrees from the University of Wisconsin.
Antiguos cargos conocidos de Larry Mattheakis.
Empresas | Cargo | Fin |
---|---|---|
ANNEXON, INC. | Chief Tech/Sci/R&D Officer | 06/01/2023 |
EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2011 |
CYTOKINETICS, INCORPORATED | Chief Tech/Sci/R&D Officer | 01/01/2007 |
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Corporate Officer/Principal | 01/01/2000 |
PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Larry Mattheakis.
University of Wisconsin | Doctorate Degree |
University of California | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
EXELIXIS, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
ANNEXON, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Commercial Services |
- Bolsa de valores
- Insiders
- Larry Mattheakis